About Emmanuelle
Emmanuelle Charpentier studied biochemistry, microbiology and genetics at the University Pierre and Marie Curie (now Sorbonne University), Paris, France (1986-1992) and obtained her Ph.D. in microbiology for her research performed at the Pasteur Institute, Paris, France (1992-1995). She then continued her scientific career in the United States, at The Rockefeller University (1996-1997), New York University Medical Center (now NYU Langone Health) (1997-1999) and the Skirball Institute of Biomolecular Medicine (1999-2002) (all in New York City, NY) and at St. Jude Children’s Research Hospital (in Memphis, TN) (1999). Emmanuelle returned to Europe to establish her own research group as a guest and then assistant professor (2002-2005) at the Institute of Microbiology and Genetics and as an associate professor (2006-2009) at the Max F. Perutz Laboratories (now Max Perutz Labs) at the University of Vienna in Austria, where she habilitated in the field of microbiology. In 2009, she was appointed as associate professor at The Laboratory for Molecular Infection Medicine Sweden (MIMS, part of Nordic European Molecular Biology Laboratory (EMBL) Partnership for Molecular Medicine) at Umeå University in Sweden (2009-2013), where she habilitated in the field of medical microbiology and served as a visiting professor (2013-2017). In 2013, Emmanuelle was appointed as the founder and head of the Department of Regulation in Infection Biology at the Helmholtz Centre for Infection Research, Braunschweig and as a full professor at the Medical School of Hannover in Germany. In 2013, she was awarded an Alexander von Humboldt professorship, which she held in 2014 and 2015. In 2015, Emmanuelle was appointed scientific member of the Max Planck Society. From 2015 to 2017, Emmanuelle was founder, scientific director and head of the Department of Regulation in Infection Biology at the Max Planck Institute for Infection Biology in Berlin, Germany. Since 2016, Emmanuelle has been an honorary professor at Humboldt University. Since 2018, she has been founding scientific and managing director of the Max Planck Unit for the Science of Pathogens (MPUSP) in Berlin, an independent Institute of the Max Planck Society. Since 2021, she has also been acting as the head of administration of MPUSP.
www.emmanuelle-charpentier.org
Additional Information (Emmanuelle/CRISPR)
contact@emmanuelle-charpentier.org
Any Requests/Questions (Emmanuelle/CRISPR)
contact@emmanuelle-charpentier.org
Public Relations (Emmanuelle/CRISPR)